Publicity 5 Sample Clauses

Publicity 5. 2 Propagace The Institution and the Investigator shall not use PSI’s or the Sponsor’s name, the names of any of their employees, symbols, or trademarks in any advertising, sales promotional material, or press release without the prior written permission of PSI or the Sponsor, as applicable. Poskytovatel a Hlavní zkoušející nebudou používat název společnosti PSI ani Zadavatele, jména jejich zaměstnanců, symboly ani ochranné známky v žádných reklamních, prodejně propagačních materiálech ani tiskových zprávách bez piedchozího písemného souhlasu PSI nebo Zadavatele.
Sample 1
AutoNDA by SimpleDocs
Publicity 5. 2. Publicita The Institution and the Investigator shall not use Sponsor’s name, the names of any of its employees and designees, symbols, or trademarks in any advertising, sales promotional material, or press release without the prior written permission of the Sponsor The Institution and Investigator grant Sponsor the right to identify the Institution and Investigator and use their name in publicity, advertising, or press releases directed at Study subject enrollment and in all listings of clinical trial sites. Zdravotnické zařízení a zkoušející nebudou používat název zadavatele, jména kterýchkoli jeho zaměstnanců a zmocněnců, symboly nebo ochranné známky v žádné reklamě, propagačních materiálech ani tiskových zprávách bez předchozího písemného svolení zadavatele. Zdravotnické zařízení a zkoušející dávají zadavateli právo identifikovat zdravotnické zařízení a zkoušejícího a používat jejich název či jméno xxx xxxxxxxxx, x xxxxxxx xxxx xxxxxxxxx xxxxxxxx xxxxxxxxxx na nábor subjektů studie a ve všech seznamech na registračních webových stránkách klinických hodnocení. 6. INDEMNIFICATION, NOTIFICATION OF CLAIMS AND INSURANCE 6. ODŠKODNĚNÍ, OZNAMOVÁNÍ POHLEDÁVEK A POJIŠTĚNÍ 6.1. Sponsor’s Indemnity Obligations 6.1. Závazky zadavatele ohledně odškodnění Sponsor undertakes to defend, indemnify and hold harmless the Institution and the Investigator against any and all third party claims, damages, losses and costs arising out of (i) material breach of this Agreement; or (ii) gross negligent or willful act or omission by Sponsor, including by its officers, employees, contractors or other staff. Sponsor indemnification shall not apply in case of (i) any negligence or intentional misconduct of Institution and or Investigator; (ii) failure of Institution and/or Investigator to comply with all Applicable Regulatory Requirements; (iii) failure of Institution and/or Investigator to perform the Study in strict compliance with (a) the Protocol and (b) all written instructions delivered by Sponsor to the Institution and/or Investigator or (iv) any breach by Institution and/or Investigator of this Agreement. Zadavatel se zavazuje, že bude bránit, odškodní a zachová bez úhony zdravotnické zařízení a zkoušejícího před veškerými pohledávkami, škodami, ztrátami a náklady třetích stran vzniklými z důvodu (i) zásadního porušení této smlouvy zadavatelem nebo (ii) hrubé nedbalosti nebo úmyslného jednání či opomenutí na straně zadavatele včetně jeho vedoucích pracovníků, zaměstnanců, ...
Sample 1
Publicity 5 
Sample 1Sample 2Sample 3

Related to Publicity 5

  • Publicity The Company, and the Buyer shall have the right to review a reasonable period of time before issuance of any press releases, SEC, OTCBB or FINRA filings, or any other public statements with respect to the transactions contemplated hereby; provided, however, that the Company shall be entitled, without the prior approval of the Buyer, to make any press release or SEC, OTCBB (or other applicable trading market) or FINRA filings with respect to such transactions as is required by applicable law and regulations (although the Buyer shall be consulted by the Company in connection with any such press release prior to its release and shall be provided with a copy thereof and be given an opportunity to comment thereon).

  • MPS LOGO/PUBLICITY No Contractor shall use the MPS Logo in its literature or issue a press release about the subject of this Contract without prior written notice to and written approval of MPS’s Executive Director of Communications & Outreach.

  • Publicity Rights (a) The Licensee grants Balsamiq the right to include the Licensee as a customer in Product promotional material.

  • PUBLICITY AND BRANDING 24.1 Subject to Clause 25 (Marketing), the Supplier shall not make any press announcements or publicise this Framework Agreement or its contents in any way without the Authority's prior Approval.

  • ADVERTISING OR PUBLICITY CONTRACTOR shall not use the name of County, its officers, directors, employees or agents, in advertising or publicity releases or otherwise without securing the prior written consent of COUNTY in each instance.

  • Publicity; Use of Names Subject to the rest of this Section 10.5, no disclosure of the existence, or the terms, of this Agreement may be made by either Party or its Affiliates, and no Party shall use the name, trademark, trade name or logo of the other Party, its Affiliates or their respective employee(s) in any publicity, promotion, news release or disclosure relating to this Agreement or its subject matter (including the Development of any Product or any Regulatory Filing or Regulatory Approval), without the prior express written permission of the other Party, except as may be required be law.

  • Publicity; Confidentiality 11.1 No news releases, public announcements, advertising materials, or confirmation of same, concerning any part of this Agreement or any Purchase Order issued hereunder shall be issued or made without the prior written approval of the Parties. Neither Party shall in any advertising, sales materials or in any other way use any of the names or logos of the other Party without the prior written approval of the other Party.

  • Announcements 4.1 Neither party will make or permit to be made any announcement or disclosure of its prospective interest in the Bid without the prior written consent of the other party.

  • Use of Names; Publicity The Funds shall not use the Distributor’s name, or any trade or service xxxx owned by or licensed to the Distributor, in any offering material, shareholder report, advertisement or other material relating to the Funds, other than for the purpose of merely identifying and describing the functions of the Distributor hereunder, in a manner not approved by the Distributor in writing prior to such use, such approval not to be unreasonably withheld. The Distributor hereby consents to all uses of its name required by FINRA, the SEC, the CFTC, any state securities commission, or any federal or state regulatory authority. The Distributor or its affiliates shall not use the name of any Fund or the name of the Managing Owner, or any trade or service xxxx owned by or licensed to the Managing Owner or any Fund in any offering material, shareholder report, advertisement or other material relating to the Distributor, other than for the purpose of merely identifying and describing the functions of the Funds hereunder, in a manner not approved by the Managing Owner in writing prior to such use, provided that in no case shall such approval be unreasonably withheld. The Managing Owner and each Fund hereby consent to all uses of its name required by FINRA, the SEC, the CFTC or any state securities commission, or any federal or state regulatory authority. The Distributor will not issue any press releases or make any public announcements regarding the existence of this Agreement without the express prior written consent of the Managing Owner. None of the Managing Owner, the Funds or the Distributor will disclose any of the economic terms of this Agreement, except as may be required by law.

  • No Publicity A party to this Agreement shall not use the name or marks of, refer to, or identify the other party (or any related entity) in any publicity releases, interviews, promotional or marketing materials, public announcements, testimonials or advertising without the prior written approval of authorized representatives of the other party (which approval a party may withhold in its sole discretion), except no such written approval is required to the extent any such disclosure is required by law. BNY Mellon may identify the Fund(s) as a client in client lists, provided that the Fund(s) name is no more prominent than any other client on such list(s). A party may withdraw such consent at any time.

Time is Money Join Law Insider Premium to draft better contracts faster.